Cargando…
Effects of Vaccination and the New Neuraminidase Inhibitor, Laninamivir, on Influenza Infection
BACKGROUND: Evidence of the effectiveness of influenza vaccination in children and elderly adults is limited, although this population has the highest risk for influenza infection. MATERIALS AND METHODS: We enrolled 4443 participants, aged 3–97 years, who had influenza-kit-positive resultsduring sea...
Autores principales: | Mizuno, Takuro, Mizuno, Shigeru, Kanda, Tsugiyasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974732/ https://www.ncbi.nlm.nih.gov/pubmed/24699254 http://dx.doi.org/10.1371/journal.pone.0092601 |
Ejemplares similares
-
Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza
por: Kashiwagi, Seizaburo, et al.
Publicado: (2016) -
Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
por: Leang, Sook-Kwan, et al.
Publicado: (2014) -
Pregnancy outcomes of women exposed to laninamivir during pregnancy
por: Minakami, Hisanori, et al.
Publicado: (2014) -
Detection of Peramivir and Laninamivir, New Anti-Influenza Drugs, in Sewage Effluent and River Waters in Japan
por: Azuma, Takashi, et al.
Publicado: (2015) -
Infective endocarditis following tumor necrosis factor-α antagonist therapy for management of psoriatic erythroderma: a case report
por: Mizuno, Takuro, et al.
Publicado: (2017)